Binary-Crosslinked Alginate/Zwitterionic Interpenetrating Polymer Network Coatings for Lubricious and Antifouling Urinary Catheters
ACS Applied Materials & Interfaces · 16.11.2026
DOI: 10.1021/acsami.6c19486 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 16.11.2026. Verfasst von Young Ho Seo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Manufacturing Technology Center, Korea Institute of Industrial Technology, Yeongcheon38822, Republic of Korea. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Ministry of Food and Drug Safety, Korea Evaluation Institute of Industrial Technology, National Research Foundation of Korea.
Abstract (Originalsprache)
Hydrophilic hydrogel coatings can mitigate catheter-associated infections and friction-induced mucosal trauma during urinary catheterization by providing hydration-driven lubrication and antifouling surfaces. Here, we report an alginate/sulfobetaine methacrylate-based zwitterionic interpenetrating polymer network (Alg-ZW IPN) that integrates a binary crosslinker system into the IPN architecture by pairing a short-chain crosslinker, N,N′-methylenebisacrylamide (MbAm), with a long-chain crosslinker, poly(ethylene glycol) dimethacrylate (PEGDMA). In the binary crosslinked IPN (Alg-ZW BIPN), MbAm establishes dense local junctions for structural integrity, while PEGDMA spans the interjunction domains to mechanically bridge the network, confine alginate chains, and stabilize Ca2+–alginate coordination. This architecture redistributes mechanical stress across length scales, thereby improving coating durability. The Alg-ZW BIPN coating exhibited ultralow friction, with a friction coefficient of 0.01–0.02, and maintained 49% lower friction than MbAm single crosslinker coatings. In catheter insertion tests using a standard vascular phantom, the coating reduced insertion force by up to 75% compared with uncoated catheters. The coating also inhibited Escherichia coli adhesion by 97.4% relative to uncoated substrates and showed excellent biocompatibility, with a hemolysis ratio of 0.17% and >95% endothelial cell viability after 24 h. Overall, the Alg-ZW BIPN design provides a general and scalable route to mechanically robust, lubricious, and antifouling hydrogel interfaces for indwelling medical devices.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Manufacturing Technology Center, Korea Institute of Industrial Technology, Yeongcheon38822, Republic of Korea.
- Department of Advanced Carbon Convergence Materials, Yeongnam Convergence Technology Campus, Korea Polytechnics, Daegu41027, Republic of Korea.
- Department of Polymer Science and Engineering, Kyungpook National University, Daegu41566, Republic of Korea.
- User Convenience Technology R&D Department, Korea Institute of Industrial Technology, Ansan15588, Republic of Korea.
ORCID-Profile: Dong Uk Lee, Woojin Kim, Dong Yun Lee, Dong Yun Choi
Förderung
- Ministry of Food and Drug Safety
- Korea Evaluation Institute of Industrial Technology
- National Research Foundation of Korea
Zitieren
APA
Seo, Y. H., Lee, D. U., Choi, J. H., Son, J. S., Kim, K. B., Kim, W., Lee, D. Y., & Choi, D. Y. (2026). Binary-Crosslinked Alginate/Zwitterionic Interpenetrating Polymer Network Coatings for Lubricious and Antifouling Urinary Catheters. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c19486
Vancouver
Seo YH, Lee DU, Choi JH, Son JS, Kim KB, Kim W, et al. Binary-Crosslinked Alginate/Zwitterionic Interpenetrating Polymer Network Coatings for Lubricious and Antifouling Urinary Catheters. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c19486
BibTeX
@article{Seo2026,
author = {Seo, Young Ho and Lee, Dong Uk and Choi, Ji Ho and Son, Jeong Sang and Kim, Kang Bin and Kim, Woojin and Lee, Dong Yun and Choi, Dong Yun},
title = {Binary-Crosslinked Alginate/Zwitterionic Interpenetrating Polymer Network Coatings for Lubricious and Antifouling Urinary Catheters},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c19486}
}
EUVIMED